Spots Global Cancer Trial Database for Lung EpiCheck Biomarkers Development Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Lung EpiCheck Biomarkers Development Study
Official Title: Lung EpiCheck Biomarkers Development Study
Study ID: NCT06245876
Conditions
Interventions
Study Description
Brief Summary: This study is part of the development of a non-invasive lung cancer screening test which aim to identify early-stage lung cancer in patients at high risk for lung cancer.
Detailed Description: This is a prospective, multi-center, observational nonsignificant risk study aimed to collect blood and clinical data from primary lung cancer and control subjects to characterize various biomarkers that will discriminate between lung cancer and control subjects.
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Life Spring Clinical Research, Miami, Florida, United States
Emerald Coast OBGYN, Panama City, Florida, United States
Ochsner LSU Health Shreveport - Regional Urology, Shreveport, Louisiana, United States
Comprehensive Urology, Southfield, Michigan, United States
Michigan Institute of Urology, P.C., Troy, Michigan, United States
Urology San Antonio, San Antonio, Texas, United States
National Koranyi Institute for Pulmonology, Budapest, , Hungary
Carmel Medical Center, Haifa, , Israel
Sourasky Medical Center, Tel Aviv, , Israel
ZGT Medical Center, Hengelo, , Netherlands
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
